U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987045) titled 'Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study' on May 15.
Brief Summary: The prostate specific antigen (PSA) blood test can help diagnose prostate problems, including cancer.
The prostate is an organ in the pelvis. It is found in cisgender men, transgender (trans) women and some non-binary people.
Anyone with a prostate can get prostate cancer. The prostate remains after genital (lower) surgery. The hormones and surgeries that trans women and non-binary people might have can lower the PSA. We do not have good data on the normal PSA levels are for this group
TransPRIDE is a research study tha...